Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
KvhKkzT2sEkV77nW
